PCV50 EFFICACY AND SOCIOECONOMIC RELEVANCE OF HAWTHORN EXTRACT (CRATAEGUS) WS® 1442 IN THE TREATMENT OF NYHA II CHF PATIENTS—RESULTS FROM A PROSPECTIVE THREE-YEAR PHARMACOECONOMIC STUDY
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63666-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)63666-2/fulltext
Title :
PCV50 EFFICACY AND SOCIOECONOMIC RELEVANCE OF HAWTHORN EXTRACT (CRATAEGUS) WS® 1442 IN THE TREATMENT OF NYHA II CHF PATIENTS—RESULTS FROM A PROSPECTIVE THREE-YEAR PHARMACOECONOMIC STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63666-2&doi=10.1016/S1098-3015(10)63666-2
First page :
Section Title :
Open access? :
No
Section Order :
516